Related Experiment Video
Updated: Apr 12, 2026

06:15
A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
Published on: July 15, 2025
1.5K
β-asarone from Acorus gramineus alleviates depression by modulating MKP-1
1Department of Pathology Qiqihar Medical University, Qiqihar, Heilongjiang Province, China.
Genetics and Molecular Research : GMR
|May 13, 2015
Summary
β-asarone administration into the hippocampus reduced depression symptoms in rats. This antidepressant effect is linked to β-asarone
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Depression is linked to dysregulation of the extracellular signal-regulated kinase (ERK) signaling pathway.
- Brain-derived neurotrophic factor (BDNF) expression, crucial for neuronal function, is regulated by ERK and implicated in depression.
- Mitogen-activated protein kinase phosphatase-1 (MKP-1) acts as a negative regulator of ERK signaling pathways.
Purpose of the Study:
- To investigate the antidepressant effects of hippocampal administration of β-asarone, a selective MKP-1 inhibitor.
- To explore the role of MKP-1 regulation by β-asarone in mediating antidepressant effects.
Main Methods:
- Utilized a rat model of depression.
- Administered β-asarone directly into the hippocampus.
- Assessed antidepressant-like behaviors and molecular changes related to MKP-1 and ERK signaling.
Main Results:
- Hippocampal administration of β-asarone demonstrated significant antidepressant effects in the rat model.
- β-asarone modulated MKP-1 activity, suggesting a mechanism for its antidepressant action.
- The study provides evidence for the involvement of the MKP-1/ERK pathway in the antidepressant effects of β-asarone.
Conclusions:
- β-asarone exhibits antidepressant properties when administered to the hippocampus in a rat model.
- Targeting MKP-1 with β-asarone represents a potential therapeutic strategy for depression by modulating the ERK signaling pathway.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
G-protein Coupled Receptors
134.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.6K

